Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.

Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.

Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins that modulate the host response to infection. Two such proteins, B14 and A52, act inside infected cells to inhibit activation of NF-kappaB, thereby blocking the production of pro-inflammatory cytokines. We have solved the cryst...

Bibliografski detalji
Glavni autori:	Graham, S, Bahar, M, Cooray, S, Chen, R, Whalen, D, Abrescia, N, Alderton, D, Owens, R, Stuart, D, Smith, G, Grimes, J
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2008

Slični predmeti

Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
od: Stephen C Graham, i dr.
Izdano: (2008-08-01)

Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
od: Benfield, C, i dr.
Izdano: (2011)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
od: Bahar Miraghazadeh, i dr.
Izdano: (2018-04-01)

NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
od: Smith, C, i dr.
Izdano: (2001)

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
od: Andreakos, E, i dr.
Izdano: (2006)

Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.
od: Cooray, S, i dr.
Izdano: (2007)

NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB.
od: Cherukuri Sudhakar, i dr.
Izdano: (2009-01-01)

Comparing the fine specificity of DNA binding by NF-kappaB p50 and p52 using principal coordinates analysis.
od: Nijnik, A, i dr.
Izdano: (2003)

Visualization of lymphatic vessels through NF-kappaB activity.
od: Saban, MR, i dr.
Izdano: (2004)

I-KappaB Expression in Patient with Psoriasis Vulgaris
od: Nahed Abdelazeem, i dr.
Izdano: (2022-04-01)

Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin.
od: Brian K Bednarski, i dr.
Izdano: (2009-09-01)

NF-kappaB Signaling in Chronic Inflammatory Airway Disease
od: Michael Schuliga
Izdano: (2015-06-01)

Compartimentalized NF-kappaB activity in the axon initial segment
od: Prehn Jochen, i dr.
Izdano: (2007-03-01)

The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules.
od: Thomas Karrasch, i dr.
Izdano: (2007-07-01)

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
od: Demetra H. Hufnagel, i dr.
Izdano: (2020-09-01)

Inhibition of Apoptosis and NF-kappa B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence
od: de Motes, C, i dr.
Izdano: (2011)

An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm.
od: Chi Zhang, i dr.
Izdano: (2006-12-01)

Haploid reporter screens aimed at identification of NF-kappaB regulators
od: Lee, Clarissa Ci
Izdano: (2014)

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
od: Feldmann, M, i dr.
Izdano: (2002)

Memory extinction entails the inhibition of the transcription factor NF-kappaB.
od: Emiliano Merlo, i dr.
Izdano: (2008-01-01)

NF-kappaB/Rel-mediated regulation of the neural fate in Drosophila.
od: Savita Ayyar, i dr.
Izdano: (2007-11-01)

Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system.
od: Anna Okvist, i dr.
Izdano: (2007-09-01)

Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host
od: Laurie T Krug, i dr.
Izdano: (2016-08-01)

Inflammatory response in a rat model of gastroschisis is associated with an increase of NF-kappaB
od: L. Sbragia, i dr.
Izdano: (2010-02-01)

Nuclear Factor-kappaB controls the reaggregation of 3D neurosphere cultures in vitro
od: D Widera, i dr.
Izdano: (2006-05-01)

How vaccinia virus has evolved to subvert the host immune response.
od: Bahar, M, i dr.
Izdano: (2011)

How vaccinia virus has evolved to subvert the host immune response
od: Bahar, M, i dr.
Izdano: (2011)

Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
od: Xiaoyu Huang, i dr.
Izdano: (2025-01-01)

The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
od: Virginie Ropars, i dr.
Izdano: (2009-08-01)

TWEAK/Fn14 and non-canonical NF-kappaB signaling in kidney disease
od: Jonay ePoveda, i dr.
Izdano: (2013-12-01)

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
od: Gyrd-Hansen, M, i dr.
Izdano: (2010)

The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis.
od: Andreakos, E, i dr.
Izdano: (2005)

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
od: Brummelkamp, T, i dr.
Izdano: (2003)

NF-kappaB regulates androgen receptor expression and prostate cancer growth.
od: Zhang, L, i dr.
Izdano: (2009)

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis.
od: Monaco, C, i dr.
Izdano: (2004)

Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
od: Bettina Sehnert, i dr.
Izdano: (2020-07-01)

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
od: Solomon Leigh A, i dr.
Izdano: (2008-11-01)

NF-kappaB mediated transcriptional repression of acid modifying hormone gastrin.
od: Dipanjana Datta De, i dr.
Izdano: (2013-01-01)

Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway
od: Jing Nianshui, i dr.
Izdano: (2019-09-01)

NF-kappaB signaling pathways in Neurological inflammation: A mini review
od: Ruey-Horng eShih, i dr.
Izdano: (2015-12-01)